- Moving away from MAU to mDAU (monetisable), a metric that shows growth.
- US 27 million, International 99 million.
ARPU
- ARPU (from ad revenue) USD 0.822 (+26.3%).
- Growth double digit now for 4 quarters.
- Total revenue +24.2% (+26% currency neutral). Four quarters in a row of 20+ percent growth.
- On a TTM basis, an acceleration to +24.5%.
- US +24.4%, International +24.0%.
- Advertising +22.8%, also 4 quarteres of 20+ percent, but down from 18Q3
- US +24.3%
- International +21.2%
- Data licensing +34.6%. Accelerating now for 4 quarters.
- US +25.4%
- International +59.9%
Margins
- Gross margin 70.5%, highest since 14Q1.
- EBITDA (income from operations) margin 22.8% at record high and 6 quarters of positive margin.
- EBIT margin 10.6%, second positive quarter (also: 17Q4).
- Profit before tax: 5 positive quarters now.
- Net profit: same.
Cash flow
- Raised $1.15b from convertible in 18Q2.
- Liquidity has been rising for many quarters and now stands at $6.24 billion.
Guidance
- Strategic focus on: Health, Conversation, Revenue products (to grow sales teams for large & medium advertisers), Platform investments.
- Revenue 19Q1 at midpoint a low +12.1%.
- Operating margin at midpoint a low 2.7%.
Geen opmerkingen:
Een reactie posten